[1. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. 2001;98(18):10344-9. DOI: 10.1073/pnas.181177898.10.1073/pnas.1811778985696311504914]Search in Google Scholar
[2. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki KI, Eguchi H, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest. 2000;105(11):1527-36. DOI: 10.1172/JCI8296.10.1172/JCI829630084710841511]Search in Google Scholar
[3. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000;97(7):3422-7. DOI: 10.1073/pnas.97.7.3422.10.1073/pnas.97.7.34221625510725398]Search in Google Scholar
[4. Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T, et al. Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina / Novelty and Significance. Circ Res. 2011;109(4):428-36. DOI: 10.1161/CIRCRESAHA.111.245993.10.1161/CIRCRESAHA.111.245993319057521737787]Search in Google Scholar
[5. Doyle B, Sorajja P, Hynes B, Kumar AHS, Araoz P a, Stalboerger PG, et al. Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev. 2008;17(5):941-51. DOI: 10.1089/scd.2007.0214.10.1089/scd.2007.0214318971218564032]Search in Google Scholar
[6. Jujo K, Ii M, Losordo DW. Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol. 2008;45(4):530-44. DOI: 10.1016/j. yjmcc.2008.08.003.]Search in Google Scholar
[7. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006;27(9):1114-22. DOI: 10.1093/eurheartj/ehi818.10.1093/eurheartj/ehi81816510464]Search in Google Scholar
[8. Herrmann JL, Abarbanell AM, Weil BR, Manukyan MC, Poynter J a, Brewster BJ, et al. Optimizing stem cell function for the treatment of ischemic heart disease. J Surg Res. 2011;166(1):138-45. DOI: 10.1016/j.jss.2010.05.057.10.1016/j.jss.2010.05.057300875920828719]Search in Google Scholar
[9. Landoni G, Bignami E, Oliviero F, Zangrillo A. Halogenated anaesthetics and cardiac protection in cardiac and non-cardiac anaesthesia. Ann Card Anaesth. 2009;12(1):4-9. DOI: 10.4103/0971-9784.4500610.4103/0971-9784.4500619136748]Search in Google Scholar
[10. Frässdorf J, De Hert S, Schlack W. Anaesthesia and myocardial ischaemia/reperfusion injury. Br J Anaesth. 2009;103(1):89-98. DOI: 10.1093/bja/aep141.10.1093/bja/aep14119502287]Search in Google Scholar
[11. Stadnicka A, Marinovic J, Ljubkovic M, Bienengraeber MW, Bosnjak ZJ. Volatile anesthetic-induced cardiac preconditioning. J Anesth. 2007;21(2):212-9. DOI: 10.1007/s00540-006-0486-6.10.1007/s00540-006-0486-617458651]Search in Google Scholar
[12. Popescu M, Munteanu A, Isvoranu G, Suciu L, Pavel B, Marinescu B, et al. Dynamics of endothelial progenitor cells following sevoflurane preconditioning. Roum Arch Microbiol Immunol. 2011 Jul-Sep;70(3):109-13.]Search in Google Scholar
[13. Lucchinetti E, Zeisberger SM, Baruscotti I, Wacker J, Feng J, Zaugg K, et al. Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics. Anesth Analg. 2009;109(4):1117-26. DOI: 10.1213/ ANE.0b013e3181b5a277.10.1213/ANE.0b013e3181b5a27719762739]Search in Google Scholar
[14. Sun X, Fang B, Zhao X, Zhang G, Ma H. Preconditioning of mesenchymal stem cells by sevoflurane to improve their therapeutic potential. PLoS One. 2014;9(3):e90667. DOI: 10.1371/journal. pone.0090667.]Search in Google Scholar
[15. Vasa M, Fichtlscherer S, Aicher a, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89(1):E1-7. DOI: 10.1161/hh1301.093953.10.1161/hh1301.09395311440984]Search in Google Scholar
[16. Hibbert B, Ma X, Pourdjabbar A, Simard T, Rayner K, Sun J, et al. Pre-procedural atorvastatin mobilizes endothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteries. PLoS One. 2011;6(1):e16413. DOI: 10.1371/journal. pone.0016413.]Search in Google Scholar
[17. Zentilin L, Tafuro S, Zacchigna S, Arsic N, Pattarini L, Sinigaglia M, et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood. 2006;107(9):3546-54. DOI: 10.1182/ blood-2005-08-3215.10.1182/blood-2005-08-321516391016]Search in Google Scholar
[18. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S, et al. VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell. 2006;124(1):175-89. DOI: 10.1016/j. cell.2005.10.036.]Search in Google Scholar
[19. Thum T, Tsikas D, Stein S, Schultheiss M, Eigenthaler M, Anker SD, et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol. 2005;46(9):1693-701. DOI: 10.1016/j.jacc.2005.04.066.10.1016/j.jacc.2005.04.06616256870]Search in Google Scholar
[20. Hibbert B, Ma X, Pourdjabbar A, Holm E, Rayner K, Chen Y-X, et al. Inhibition of endothelial progenitor cell glycogen synthase kinase-3beta results in attenuated neointima formation and enhanced re-endothelialization after arterial injury. Cardiovasc Res. 2009;83(1):16-23. DOI: 10.1093/cvr/cvp156.10.1093/cvr/cvp15619454488]Search in Google Scholar
[21. Hirschi KK, Ingram D a., Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008;28(9):1584-95. DOI: 10.1161/ATVBAHA.107.155960.10.1161/ATVBAHA.107.155960524481318669889]Search in Google Scholar
[22. Bedirli N, Bagriacik EU, Emmez H, Yilmaz G, Unal Y, Ozkose Z. Sevoflurane and Isoflurane Preconditioning Provides Neuroprotection by Inhibition of Apoptosis-related mRNA Expression in a Rat Model of Focal Cerebral Ischemia. J Neurosurg Anesthesiol. 2012;24(4):336-44. DOI: 10.1097/ ANA.0b013e318266791e.10.1097/ANA.0b013e318266791e22871953]Search in Google Scholar
[23. Codaccioni J-L, Velly LJ, Moubarik C, Bruder NJ, Pisano PS, Guillet B a. Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome. Anesthesiology. 2009;110(6):1271-8. DOI: 10.1097/ALN.0b013e3181a1fe68.10.1097/ALN.0b013e3181a1fe6819417596]Search in Google Scholar
[24. Liu Y, Shi L, Liu C, Zhu G, Li H, Zhao H, et al. Effect of combination therapy of propofol and sevoflurane on MAP2K3 level and myocardial apoptosis induced by ischemia-reperfusion in rats. Int J Clin Exp Med. 2015 Apr 15;8(4):6427-35.]Search in Google Scholar
[25. Zhang J, Wang C, Yu S, Luo Z, Chen Y, Liu Q, et al. Sevoflurane Postconditioning Protects Rat Hearts against Ischemia-Reperfusion Injury via the Activation of PI3K/AKT/mTOR Signaling. Sci Rep. 2014;4:7317. DOI: 10.1038/srep07317.10.1038/srep07317425518225471136]Search in Google Scholar
[26. Zhang YL, Yao YT, Fang NX, Zhou CH, Gong JS, Li LH. Restoration of autophagic flux in myocardial tissues is required for cardioprotection of sevoflurane postconditioning in rats. Acta Pharmacol Sin. 2014 Jun;35(6):758-69. DOI: 10.1038/aps.2014.20.10.1038/aps.2014.20408639324793309]Search in Google Scholar
[27. Theus MH, Wei L, Cui L, Francis K, Hu X, Keogh C, et al. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Experimental Neurology. 2008. p. 656-70. DOI: 10.1016/j.expneurol.2007.12.020.10.1016/j.expneurol.2007.12.02018279854]Search in Google Scholar
[28. Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang J-A, et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg [Internet]. 2008;135(4):799-808. DOI: 10.1016/j.jtcvs.2007.07.071.10.1016/j.jtcvs.2007.07.07118374759]Search in Google Scholar
[29. Akita T, Murohara T, Ikeda H, Sasaki K-I, Shimada T, Egami K, et al. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest. 2003;83(1):65-73. DOI: 10.1097/01.LAB.0000050761.67879.E4.10.1097/01.LAB.0000050761.67879.E412533687]Search in Google Scholar
[30. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106(22):2781-6. DOI: 10.1161/01.CIR.0000039526.42991.93.10.1161/01.CIR.0000039526.42991.93]Search in Google Scholar